Mavacamten in real‐life practice: Initial experience at a hypertrophic cardiomyopathy centre

Mavacamten in real‐life practice: Initial experience at a hypertrophic cardiomyopathy centre

Abstract Aims In clinical trials, mavacamten reduced left ventricular outflow tract obstruction (LVOTO) and improved symptoms in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). We aimed to share our real‐world experience with the efficacy and safety of mavacamten in this pa...

Full description

Bibliographic Details
Main Authors: Zaid Abood, Muhammad Fuad Jan, Muddasir Ashraf, Stacie Kroboth, Heather Sanders, McKenzie Schweitzer, Amanda Misicka, Emily Ollerman, Arshad Jahangir, Patrycja Galazka, Abdul Jamil Tajik
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ESC Heart Failure
Subjects:
left ventricular outflow tract obstruction
mavacamten
obstructive hypertrophic cardiomyopathy
Online Access:https://doi.org/10.1002/ehf2.14882

Internet

https://doi.org/10.1002/ehf2.14882

Similar Items